Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
Increased capability to produce medicines for challenging diseases including cancer
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Subscribe To Our Newsletter & Stay Updated